CIK 0001896212 · <br>Emerging growth company
CDT Equity Inc.
Sign in to watch- Ticker
- CDT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 873272543
- Phone
- (646) 491 9132
- Business address
- 4851 TAMIAMI TRAIL NORTH, SUITE 200, NAPLES, FL, 34103
- Former names
- CONDUIT PHARMACEUTICALS INC., Murphy Canyon Acquisition Corp.
Securities
- CDT Common Stock Nasdaq
- CDTTW Warrant Nasdaq
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 8-K/A Event Acquisition or sale completed
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Unregistered share sale
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Auditor change
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Delisting notice · Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- NT 10-Q Other NT 10-Q
- 8-K Event Material agreement
- SCHEDULE 13D/A Stake Beneficial Ownership Report
Page 3 of 19 · 371 filings